Lewington VJ - Search Results

1

The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.

Cook GJ, Venkitaraman R, Sohaib AS, Lewington VJ, Chua SC, Huddart RA, Parker CC, Dearnaley DD, Horwich A. Cook GJ, et al. Among authors: lewington vj. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):7-13. doi: 10.1007/s00259-010-1576-0. Epub 2010 Aug 10. Eur J Nucl Med Mol Imaging. 2011. PMID: 20697891 Clinical Trial.

2

18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin).

Cook G Jr, Parker C, Chua S, Johnson B, Aksnes AK, Lewington VJ. Cook G Jr, et al. Among authors: lewington vj. EJNMMI Res. 2011 Jun 7;1(1):4. doi: 10.1186/2191-219X-1-4. EJNMMI Res. 2011. PMID: 22214491 Free PMC article.

3

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases.

Chittenden SJ, Hindorf C, Parker CC, Lewington VJ, Pratt BE, Johnson B, Flux GD. Chittenden SJ, et al. Among authors: lewington vj. J Nucl Med. 2015 Sep;56(9):1304-9. doi: 10.2967/jnumed.115.157123. Epub 2015 Jul 16. J Nucl Med. 2015. PMID: 26182965 Free article. Clinical Trial.

4

The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.

Kong G, Jackson C, Koh DM, Lewington V, Sharma B, Brown G, Cunningham D, Cook GJ. Kong G, et al. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1323-9. doi: 10.1007/s00259-008-0743-z. Epub 2008 Mar 18. Eur J Nucl Med Mol Imaging. 2008. PMID: 18347794

5

¹⁸F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients.

O'Doherty J, Jauregui-Osoro M, Brothwood T, Szyszko T, Marsden PK, O'Doherty MJ, Cook GJR, Blower PJ, Lewington V. O'Doherty J, et al. J Nucl Med. 2017 Oct;58(10):1666-1671. doi: 10.2967/jnumed.117.192252. Epub 2017 Apr 6. J Nucl Med. 2017. PMID: 28385795 Free PMC article.

6

Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review.

Targeted Alpha Therapy Working Group; Parker C, Lewington V, Shore N, Kratochwil C, Levy M, Lindén O, Noordzij W, Park J, Saad F. Targeted Alpha Therapy Working Group, et al. JAMA Oncol. 2018 Dec 1;4(12):1765-1772. doi: 10.1001/jamaoncol.2018.4044. JAMA Oncol. 2018. PMID: 30326033 Review.

7

Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer.

Du Y, Carrio I, De Vincentis G, Fanti S, Ilhan H, Mommsen C, Nitzsche E, Sundram F, Vogel W, Oyen W, Lewington V. Du Y, et al. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1671-1678. doi: 10.1007/s00259-017-3756-7. Epub 2017 Jun 19. Eur J Nucl Med Mol Imaging. 2017. PMID: 28631036 Free PMC article.

8

Advances in targeted alpha therapy for prostate cancer.

De Vincentis G, Gerritsen W, Gschwend JE, Hacker M, Lewington V, O'Sullivan JM, Oya M, Pacilio M, Parker C, Shore N, Sartor O; Targeted Alpha Therapy Prostate Working Group. De Vincentis G, et al. Ann Oncol. 2019 Nov 1;30(11):1728-1739. doi: 10.1093/annonc/mdz270. Ann Oncol. 2019. PMID: 31418764 Free PMC article. Review.

9

89Sr therapy: strontium plasma clearance in disseminated prostatic carcinoma.

Blake GM, Wood JF, Wood PJ, Zivanovic MA, Lewington VJ. Blake GM, et al. Among authors: lewington vj. Eur J Nucl Med. 1989;15(1):49-54. doi: 10.1007/BF00253599. Eur J Nucl Med. 1989. PMID: 2537216

10

Targeted radionuclide therapy for bone metastases.

Lewington VJ. Lewington VJ. Eur J Nucl Med. 1993 Jan;20(1):66-74. doi: 10.1007/BF02261248. Eur J Nucl Med. 1993. PMID: 7678397 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page